BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24380965)

  • 1. [Behavioural studies during the gestational-lactation period in morphine treated rats].
    Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?
    Sobor M; Timár J; Riba P; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Pharmacol Biochem Behav; 2010 May; 95(3):367-74. PubMed ID: 20193708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate regulation of behavioral selection during lactation.
    Sukikara MH; Platero MD; Canteras NS; Felicio LF
    Pharmacol Biochem Behav; 2007; 87(3):315-20. PubMed ID: 17624414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine treatment during pregnancy modulates behavioral selection in lactating rats.
    Cruz Ade M; Maiorka PC; Canteras NS; Sukikara MH; Felicio LF
    Physiol Behav; 2010 Aug; 101(1):40-4. PubMed ID: 20416331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine pretreatment increases opioid inhibitory effects on maternal behavior.
    Miranda-Paiva CM; Nasello AG; Yin AJ; Felicio LF
    Brain Res Bull; 2001 Jul; 55(4):501-5. PubMed ID: 11543950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring.
    Timár J; Sobor M; Király KP; Gyarmati S; Riba P; Al-Khrasani M; Fürst S
    Behav Pharmacol; 2010 Feb; 21(1):58-68. PubMed ID: 20038835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
    Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.
    Vargas-Perez H; Ting-A-Kee RA; Heinmiller A; Sturgess JE; van der Kooy D
    Eur J Neurosci; 2007 Jun; 25(12):3713-8. PubMed ID: 17610590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine.
    Timár J; Gyarmati Z; Fürst Z
    Brain Res Bull; 2005 Jan; 64(5):417-24. PubMed ID: 15607829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.